Bimekizumab infection rates in patients with moderate to severe plaque psoriasis: Analysis of pooled data from 2 years of treatment in phase 3 and 3b clinical trials
Authors: April Armstrong, Richard G. Langley, Kenneth B. Gordon, Richard B. Warren, Diamant Thaçi, Linda Stein Gold, Luke Peterson, Cynthia Madden, Natalie Nunez Gomez, Dirk de Cuyper, Antonio Costanzo